Patrick Burkett
Overview
Explore the profile of Patrick Burkett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
690
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muralidharan K, Karumanchi S, Kowalski K, Burkett P, Chapel S, Rajagovindan R, et al.
J Clin Pharmacol
. 2022 Mar;
62(8):1030-1046.
PMID: 35285968
Amyloid-related imaging abnormalities with edema (ARIA-E) have been reported in patients with early Alzheimer disease treated with aducanumab. ARIA-E incidence has been observed to be dependent on both dose and...
2.
Salloway S, Chalkias S, Barkhof F, Burkett P, Barakos J, Purcell D, et al.
JAMA Neurol
. 2021 Nov;
79(1):13-21.
PMID: 34807243
Importance: The EMERGE and ENGAGE phase 3 randomized clinical trials of aducanumab provide a robust data set to characterize amyloid-related imaging abnormalities (ARIA) that occur with treatment with aducanumab, an...
3.
Courtwright A, Lamattina A, Louis P, Trindade A, Burkett P, Imani J, et al.
Sci Rep
. 2019 Jun;
9(1):9003.
PMID: 31227795
Hyaluronan (HA) is associated with innate immune response activation and may be a marker of allograft dysfunction in lung transplant recipients. This was a prospective, single center study comparing levels...
4.
Cao S, Courtwright A, Lamattina A, Guleria I, Burkett P, El-Chemaly S, et al.
J Heart Lung Transplant
. 2017 Dec;
37(4):531-533.
PMID: 29229269
No abstract available.
5.
Courtwright A, Burkett P, Divo M, Keller S, Rosas I, Trindade A, et al.
Ann Thorac Surg
. 2017 Dec;
105(2):441-447.
PMID: 29223419
Background: Epstein-Barr virus (EBV) donor positive/recipient negative (D+/R-) status is a significant risk factor for posttransplant lymphoproliferative disorder (PTLD) in lung transplant. There are, however, no studies that identify the...
6.
Moniodis A, Townsend K, Rabin A, Aloum O, Stempel J, Burkett P, et al.
J Heart Lung Transplant
. 2017 Apr;
37(3):340-348.
PMID: 28431983
Background: Survival after lung transplantation is limited by chronic lung allograft dysfunction (CLAD). Immunomodulatory therapies such as extracorporeal photopheresis (ECP) and alemtuzumab (AL) have been described for refractory CLAD, but...
7.
Courtwright A, Salomon S, Fuhlbrigge A, Divo M, Rosas I, Camp P, et al.
Clin Transplant
. 2016 Jun;
30(9):1053-8.
PMID: 27312895
Unplanned early rehospitalization (UER), defined as an unscheduled admission within 30 days of a hospital discharge, is associated with graft loss and recipient mortality in some solid organ transplants but...
8.
Jacob S, Courtwright A, El-Chemaly S, Racila E, Divo M, Burkett P, et al.
Eur J Cardiothorac Surg
. 2015 Oct;
49(5):1344-7.
PMID: 26468269
Objectives: Fat embolism is a known complication of severe trauma and closed chest cardiac resuscitation both of which are more common in the lung transplant donor population and can lead...
9.
Ma A, Koka R, Burkett P
Annu Rev Immunol
. 2006 Mar;
24:657-79.
PMID: 16551262
IL-2, IL-15, and IL-7 are cytokines that are critical for regulating lymphoid homeostasis. These cytokines stimulate similar responses from lymphocytes in vitro, but play markedly divergent roles in lymphoid biology...
10.
Koka R, Burkett P, Chien M, Chai S, Boone D, Ma A
J Immunol
. 2004 Sep;
173(6):3594-8.
PMID: 15356102
NK cells protect hosts against viral pathogens and transformed cells, and dendritic cells (DCs) play important roles in activating NK cells. We now find that murine IL-15Ralpha-deficient DCs fail to...